Silence Therapeutics reported $3.73M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
AstraZeneca USD 5.8B 735M Jun/2026
Autolus Therapeutics Ltd USD 39.95M 4.16M Mar/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Novartis USD 3.24B 101M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
Silence Therapeutics USD 3.73M 2.06M Dec/2025